Greybrook actively invests equity on behalf of individual and institutional investors in large-scale real estate developments. Playing an active management role, we collaborate alongside their roster of top-tier execution partners to drive results.

Their growing North American real estate investment portfolio includes more than 75 million square feet of projected density with an estimated completion value of over $40 billion and includes notably, the Waldorf Astoria Hotel & Residences Miami, 138 Yorkville – ultra luxury residences, and their Society Living platform, an innovative approach to purpose-built Class A multi-family. Their management team has built a reputation for identifying business opportunities.

Through an exclusively principal investment strategy, Greybrook has made notable investments in Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS), a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders founded by Greybrook with over 125 clinics across the U.S., and Delos, the pioneer and global authority on the health and wellness of humans in the places where we live, eat, sleep and play, and the founder of the International WELL Building Institute and WELL Building Standard.